Table 1.
Author/year | Design | Timeframe of procedures | Centers | Country | Cohort | Group | N | Age (years) | Male |
---|---|---|---|---|---|---|---|---|---|
Tanaka‐Esposito (2013)8 |
Retrospective cohort 2 phases |
January 2005‐December 2006 | 1 | United States | Atrial fibrillation | Conventional | 1909 | 62.9 | 63% |
July 2008‐May 2010 | Ultrasound | 1511 | 63.1 | 60% | |||||
Errahmouni (2014)9 |
Retrospective cohort Historic controls |
April 2012‐October 2012 | 1 | Monaco | All arrhythmias | Conventional | 150 | Not reported | 79% |
November 2012‐June 2013 | Ultrasound | 150 | 77% | ||||||
Wynn (2014)10 |
Prospective cohort 2 phases |
May 2012‐September 2012 | 1 | United Kingdom | Atrial fibrillation | Conventional | 146 | 58.7 | 68% |
October 2012‐February 2013 | Ultrasound | 163 | 59.1 | 74% | |||||
Rodriguez (2015)11 | Prospective Cohort | Not reported | 1 | Spain | All arrhythmias | Conventional | 12 | 57 | 61% |
Ultrasound | 24 | 58 | 49% | ||||||
Dussault (2016)12 | Retrospective cohort | January 2010‐October 2015 | 1 | United States |
Atrial fibrillation/ Atrial flutter |
Conventional | 757 | 65.4 | 67% |
Ultrasound | 439 | 64.2 | 64% | ||||||
Sharma (2016)13 |
Prospective Cohort 2 phases |
October 2014‐May 2015 | 1 | United States | All arrhythmias | Conventional | 349 | 65.4 | 42% |
June 2015‐January 2016 | Ultrasound | 340 | 64.2 | 83% | |||||
Yamagata (2018)14 | Randomised trial | March 2016‐November 2016 | 4 |
Czech Republic Japan |
Atrial fibrillation | Conventional | 160 | 61.2 | 72% |
Ultrasound | 159 |